Ubiquitin E3 ligase β‐TrCP negatively regulates surface protein of hepatitis B virus
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.28620 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Wenhui Tu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The Second Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Ubiquitin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Chronic hepatitis B (CHB) still cannot be cured currently, while the pursuit of a functional cure seems to be an accessible goal, in which the condition mainly depends on the serum hepatitis B surface antigen (HBsAg) levels. HBsAg may be downregulated by protein ubiquitination, which may facilitate finding a new potential intervention target for functional cure of CHB. We confirmed that β‐transducin repeat‐containing protein (β‐TrCP) was the E3 ubiquitin ligase of HBsAg. β‐TrCP specifically downregulated the expression of Myc‐HBsAg. The degradation of Myc‐HBsAg occurred via the proteasome pathway. Knockdown of β‐TrCP increased Myc‐HBsAg levels in HepG2 cells. The study further indicated that β‐TrCP could affect the K48‐linked polyubiquitin chain by acting on Myc‐HBsAg. The GS 137 G motif of HBsAg protein is required for β‐TrCP‐mediated degradation. Furthermore, we found that β‐TrCP could significantly inhibit both intracellular and extracellular HBsAg levels produced by pHBV‐1.3. Our study demonstrated that the E3 ubiquitin ligase β‐TrCP induces K48‐linked polyubiquitination of HBsAg, promotes the ubiquitination degradation of HBsAg, and downregulates intra‐ and extracellular HBsAg levels. Therefore, using the ubiquitination degradation pathway of HBsAg, it is possible to reduce HBsAg levels in CHB patients, which may be helpful in obtaining the goal of functional cure in the treatment of CHB patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Infectious Diseases, Taizhou Municipal Hospital, Taizhou, China.
- Department of Infectious Diseases, The Affiliated Infectious Diseases Hospital, Suzhou Medical College of Soochow University, Suzhou, China.
- Department of Hepatology, The Fifth People's Hospital of Suzhou, Suzhou, China.
- International Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China.
ORCID-Profile: Wenhui Tu, Chuanwu Zhu
Förderung
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
Zitieren
APA
Tu, W., Liu, J., Qian, F., Zhu, L., Li, M., Zheng, H., & Zhu, C. (2023). Ubiquitin E3 ligase β‐TrCP negatively regulates surface protein of hepatitis B virus. Journal of Medical Virology. https://doi.org/10.1002/jmv.28620
Vancouver
Tu W, Liu J, Qian F, Zhu L, Li M, Zheng H, et al. Ubiquitin E3 ligase β‐TrCP negatively regulates surface protein of hepatitis B virus. Journal of Medical Virology. 2023. doi:10.1002/jmv.28620
BibTeX
@article{Tu2023,
author = {Tu, Wenhui and Liu, Jin and Qian, Feng and Zhu, Li and Li, Ming and Zheng, Hui and Zhu, Chuanwu},
title = {Ubiquitin E3 ligase β‐TrCP negatively regulates surface protein of hepatitis B virus},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.28620}
}
EUVIMED